Subscribe:
RSS feed
Delivering Understanding Beyond Insights
Browsing All posts tagged under »Navigating the healthcare maze«
The Universal challenges of health care procurement
June 1, 2011
It seems that hardly a week goes by when there isn’t one story or another involving health care. From Medicaid reform to the spiraling costs tied to an increase in chronic illnesses – according to health care expert and author of the book Navigating The Healthcare Maze Jeff Knott, a surprisingly large percentage of the […]
Social Media and Health Care: Integrating Health Care to Improve Patient Care
June 7, 2010
“Health care is the most information-intensive industry, yet it lags behind every other sector of the national economy in its adoption of information technology,” Mongiardo said. “The banking industry is 20 years ahead of health care in implementing information technology. A Request for Proposal (RFP) has been issued seeking vendors to help establish this information […]
MET Life has Snoopy . . . now MedVision has Alfie (What’s It All About?)
June 5, 2010
Before anyone is mistakenly led to believe that Michael Caine (or Jude Law for the younger set) has become the spokesperson for Tampa-based MedVision, a medical consulting, healthcare planning, risk management, and wellness consulting firm for self-funded employer plan sponsors, neither are the Alfie’s to which I am referring. Alfie, as it turns out is […]
Are American Hospitals A Seething Cauldron of Potential Disease?
April 9, 2010
After surviving a motorcycle crash in 2006, David Meyer–a healthy, active man in his 50s–never guessed that the broken ankle he suffered in the crash would be the least of his worries. He underwent surgery for his ankle, endured four more operations, an intensive antibiotic program and debilitating pain–not because of the accident, but because […]
Procurement Insights 
Pharma Supply Chains (Part 1): A problem of focus versus avarice?
October 11, 2011
2
A report from PricewaterhouseCoopers (PwC) entitled “Supplying The Future: Which Path Will You Take?”, believes that the pharmaceutical supply chain will not be able to cope with new products as it is inefficient and underused. The reason for this conclusion is that PwC believe pharmaceutical companies are too focused on developing new products and regulatory […]